HOME › DRUGS › CRIZANLIZUMAB
ACTIVE SUBSTANCE / INN

CRIZANLIZUMAB

Brand name(s): Adakveo
EMA LISTED
REVOKED
Anemia, Sickle Cell
ACTIVE SUBSTANCE
Crizanlizumab
REGULATORS
EMA
SPONSORS / MAH
Novartis Europharm Limited
TOTAL APPLICATIONS
1
EMA AUTHORISATIONS
PRODUCT NAMEHOLDERSTATUSDATEINDICATION
AdakveoNovartis Europharm LimitedRevoked28/10/2020Anemia, Sickle Cell

FULL INTELLIGENCE ON CRIZANLIZUMAB

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →